Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
Plymouth Pharmaceuticals and Dermatologist Cited in ‘Skin and Allergy News’ Regarding Drug’s (Acunol™) Role in Preventing Jewelry Allergy
The respected journal “Skin & Allergy News” recently released “Nickel Named Contact Allergen of the Year” in its current issue. Researcher Dr Katherine A Zug, of the Department of Dermatology at Dartmouth Hitchcock Medical Center in Lebanon, NH, has published her... - April 10, 2008 - Plymouth Pharmaceuticals Inc
Chris Austin to Give Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
Chris Austin, Director of the NIH Chemical Genomics Center to give Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA Dr. Christopher P. Austin, Director of the NIH Chemical Genomics Center will give the Keynote... - April 10, 2008 - GTCbio
Clay Scott, Associate Director of Lead Generation at AstraZeneca to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
Dr. Clay Scott, Associate Director of the Lead Generation Department at AstraZeneca will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Clay will speak on experiences in lead generation focusing on cellular... - April 03, 2008 - GTCbio
Taosheng Chen, Director of HTS, St. Jude Children's Research Hospital to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference
Dr. Taosheng Chen, Director of HTS, St. Jude Children's Research Hospital will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Chen will speak on a chemical biology approach to identify modulators of xenobiotic... - April 03, 2008 - GTCbio
Xi Chen, Assistant Professor at University of California, Davis to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
Dr. Xi Chen, Assistant Professor in the Department of Chemistry at the University of California, Davis will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. - April 03, 2008 - GTCbio
John Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
John Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA Dr. John W. Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline will present at GTCbio’s 3rd... - April 03, 2008 - GTCbio
Hakim Djaballah, Director of HTS at Memorial Sloan Kettering Cancer Center to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference
Dr. Hakim Djaballah, Director of High Throughput Screening Core Facility at the Memorial Sloan Kettering Cancer Center will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Djaballah will speak on successful... - April 03, 2008 - GTCbio
Dr. Karim Dabbagh to Present at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6
Dr. Karim Dabbagh the Director of Pharmacology at Hoffmann-La Roche will present at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. - March 30, 2008 - GTCbio
Dr. Susan Taylor to Give Featured Presentation at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference
Dr. Susan Taylor, Professor of Pharmacology at UCSD, will be giving the Featured Presentation at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. - March 30, 2008 - GTCbio
AnaSpec Offers Fluo-3 - a High Affinity Fluorescent Calcium Indicator
Calcium plays a vital role in the specific and selective regulation of major cellular processes and is central in the regulation of cardiac contractility, growth and gene expression. Calcium indicators are small molecules that can respond to the binding of Ca2+ ions by changing their spectral... - March 29, 2008 - AnaSpec, EGT Group
Berta Strulovici of Merck & Co. to Give Keynote Presentation at GTCbio’s 3rd Assay Development
Dr. Berta Strulovici, Vice President of Basic Research MRL, and Automated Biotechnology Head at Merck & Co. will give Keynote Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. - March 28, 2008 - GTCbio
Robert Hertzberg of GlaxoSmithKline to Give Keynote Presentation at GTCbio’s 3rd Assay Conference
Dr. Robert Hertzberg, Vice President of Screening & Compound Profiling at GlaxoSmithKline will give the Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Hertzberg will present on “High Throughput Screening: A Technology That’s Easy to Love and Easy to Hate.” - March 28, 2008 - GTCbio
North Carolina Biotechnology Center Renames Faculty Recruitment Grant to Honor Dr. Oliver Smithies
The North Carolina Biotechnology Center (www.ncbiotech.org) has announced its Faculty Recruitment Grant has been renamed the Oliver Smithies Faculty Recruitment Grant in honor of Nobel Prize recipient, Dr. Oliver Smithies. The North Carolina Biotechnology Center created the Faculty Recruitment... - March 28, 2008 - North Carolina Biotechnology Center
AnaSpec Introduces Suite of Labeled & Unlabeled Anti-Actin Antibodies
AnaSpec has introduced a suite of labeled and unlabeled anti-Actin antibodies. - March 26, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New Technical Support Solution
This month AnaSpec introduced a significantly improved online technical support resource for its website users. AnaSpec's new Frequently Asked Questions (FAQ) Page now offers a searchable database of solutions that offers a more convenient and more comprehensive solution for technical support needs. - March 22, 2008 - AnaSpec, EGT Group
The Hamner Institutes for Health Sciences Announces New Board Appointments
The Hamner Institutes for Health Sciences (www.thehamner.org) has announced new additions to its 2008 Board of Directors. New members include Dr. Enriqueta C. Bond, president of The Burroughs Wellcome Fund, Robert C. Eubanks, founder and president of Franklin Street Partners, and Dr. Garheng Kong,... - March 20, 2008 - The Hamner Institutes for Health Sciences
Steriods on Barcode
Simple barcodes come of age. Immunoassays on barcodes seamlessly convey medical and drug abuse results, track patient progress and even alert patients of impending health problems. - March 20, 2008 - Prognosys LLC
North Carolina Biotechnology Center Announces Podcast Featuring Dr. Oliver Smithies
The North Carolina Biotechnology Center (www.ncbiotech.org) has announced the release of a podcast featuring Dr. Oliver Smithies, co-recipient of the 2007 Nobel Prize in physiology or medicine. In the podcast, Smithies discusses how he was recruited to the University of North Carolina at Chapel... - March 19, 2008 - North Carolina Biotechnology Center
AnaSpec Introduces Phosphopeptide Standards Kit
AnaSpec has introduced a dependable tool for the analysis and characterization of phosphorylated peptides – AnaSpec’s Phosphopeptide Standards Kit. - March 19, 2008 - AnaSpec, EGT Group
AnaSpec Introduces 58 New Antibody Products
Continuing to rapidly expand its antibody offerings, AnaSpec has added fifty-eight (58) new antibody products to its growing collection. Anti-PTEN (pSer385) (polyclonal) - Cat# 29642-025, 25 µg Host: rabbit polyclonal; Species Reactivity: human; rat; mouse; Applications: IP; WB;... - March 16, 2008 - AnaSpec, EGT Group
NCSRT Launches DiaSync for Improved Yield, Lower Cost in Harvest, Concentration, and Diafiltration of Biomolecules
At the Antibody Development and Production meeting in San Diego, CA March 12, 2008, NCSRT is launching its DiaSync process for biomolecules from fermentation, cell culture, or extraction. Utilizing concurrent processing technology and the patented SmartFlow™ TFF technology, DiaSync provides... - March 12, 2008 - NCSRT, Inc.
The Hamner Institutes for Health Sciences Signs b3bio, Inc.
The Hamner Institutes for Health Sciences (www.thehamner.org) has announced that b3bio, Inc. has joined The Hamner Accelerator for Translational Bioscience. The accelerator program provides an opportunity for leaders of emerging companies and academic institutions to access resources at The Hamner... - March 11, 2008 - The Hamner Institutes for Health Sciences
AnaSpec Introduces New SensoLyte™ Cathepsin D Activity Assay Kits
AnaSpec has introduced a new series of SensoLyte™ Cathepsin D Activity Assay Kits to address the issue of autofluorescence interference. - March 09, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Two Novel Amino Acids
AnaSpec has introduced two novel amino acids that offer additional tools and functionality for peptide chemists. - March 05, 2008 - AnaSpec, EGT Group
ClinfoSource and Nucleus Network Jointly Launch On-Line GCP Clinical Trials Training Programs for the Australia-New Zealand Region
ClinfoSource, a US-based global online training company has partnered with Nucleus Network of Australia to provide web-based GCP training for clinical trials professionals in the Australia region, later to be extended to include New Zealand regulations. This program will offer clinical trial investigators, coordinators, research associates and others a solid and practical understanding of clinical trials conduct and management, the regulations and ethics central to the drug development process. - February 28, 2008 - ClinfoSource
Colorado Biosciences Get Boost, Advancing Major Economic Development Program
The Colorado House gave a big boost to a critical economic development project on Tuesday. A bill expanding Colorado’s much lauded Bioscience Discoveries Grant Program passed the House by an initial voice vote. House Bill 1001, sponsored by State Representative Jim Riesberg (D-Greeley), will make $26.5 million available in grants over the next five years. HB 1001 will provide as much as $150,000 per project to Colorado research institutions, accelerating the development of new technologies. - February 28, 2008 - Colorado BioScience Association
AnaSpec Introduces 9 New Antibody Products
AnaSpec added nine new antibody products to its growing collection. - February 28, 2008 - AnaSpec, EGT Group
BioGoa 2008 - "Entrepreneurship & Technologies in Biotechnology" Seminar to be Organised by GSIA on 1st March, 2008 at Hotel Fidalgo, Panaji, Goa, India
The main aim of the seminar is to create Entrepreneurship Skills in Biotechnology sector among local youth and thereby generate gainful employment which is a win-win situation for industry as well as entrepreneurs. - February 27, 2008 - Goa State Industries Association
AnaSpec Introduces 5 New Peptide Synthesis Reagents
AnaSpec added five (5) new peptide synthesis reagents to its combinatorial chemistry collection. - February 24, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Collection of Channel Blocker Peptides
AnaSpec has introduced its selection of channel blocker peptides. - February 21, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New Suite of Fluorescently Labeled GST & 6xHis Tag Antibodies
AnaSpec has introduced a suite of fluorescently labeled GST and 6X-His antibodies. These antibodies are labeled with a selection of dyes, including AnaSpec’s proprietary HiLyte FluorTM and HiLytePlusTM dyes, which span the visible spectrum. This gives researchers a wide range of wavelength... - February 16, 2008 - AnaSpec, EGT Group
ZYTO Corp. Uses Editor Based LinksManager.com to Generate Relevant Traffic and to Improve SEO
ZYTO Corp. uses an automated online reciprocal link software to improve search engine optimization. The use of the service saves time and money, and gets results, according to company officials. - February 15, 2008 - Zyto Corp.
Quick-Med Technologies’ Research & Development Center Moves to New Location
Expanding its Research & Development Center in Gainesville - February 14, 2008 - FCJ Retreat & Conference Centre
AnaSpec Introduces 46 New Antibody Products
Continuing to rapidly expand its antibody offerings, AnaSpec added forty-six (46) new antibody products to its growing collection. Anti - GST Tag AMCA labeled - Cat# 29531-AMCA, 100 µg Host: mouse monoclonal; Application: IHC Anti - GST Tag Biotin labeled - Cat# 29531-BIOT, 100... - February 13, 2008 - AnaSpec, EGT Group
Dr. Olderman Highlights Value of Bonded Antimicrobial at Textiles Conference
Quick-Med Technologies (OTCBB: QMDT)’s Vice President of Research & Development and Commercialization, Gerald M. Olderman, Ph.D., presented “Unique and New: A Bonded Antimicrobial Concept,” at the recent Summit Session on Antimicrobials in Plastic and Textile Applications... - February 12, 2008 - FCJ Retreat & Conference Centre
AnaSpec Introduces 21 New Anti-Tau Antibodies
AnaSpec has announced the release of 21 new anti-Tau antibodies. Complementing one of the world’s most comprehensive collections of beta-amyloid peptides, this new selection of anti-Tau antibodies demonstrates AnaSpec’s efforts to deliver new solutions for Alzheimer research. Tau is a... - February 11, 2008 - AnaSpec, EGT Group
Experts Convene Forum to Harmonize Plant Biotechnology Regulations in Southeast Asia
Plant biotechnology regulators and decision-makers from all over Southeast Asia will convene for a learning forum on Rationalizing and Harmonizing Plant Biotechnology Regulations in Southeast Asia (SEA) in Bangkok, Thailand. The learning forum will be held on 4-7 March 2008 at Miracle Grand Hotel,... - February 10, 2008 - Southeast Asian Regional Center for Graduate Study and Research in Agriculture
NCSRT Presents SmartFlow™ TFF Performance Advantages Over Centrifugation and Microfiltration for Monoclonal Antibody Recovery, Concentration and Diafiltration
NCSRT is presenting “A comparison of product yield using either centrifugation and microfiltration or simultaneous membrane processing with SmartFlow™ TFF” at the Waterside Conference in Miami, FL. The data, generated by Viventia Biotech of Winnipeg, Manitoba, Canada, demonstrates... - February 08, 2008 - NCSRT, Inc.
CDR Enters Into a Distribution Agreement with Unity Scientific
Beginning January 2008, CDR will entrust Unity Scientific Asia Pacific Pty Ltd with the exclusive distribution of FoodLab line of products in Australia and New Zealand. - January 31, 2008 - CDR s.r.l.
Ron Newcomb Named President & CEO of Resveratrol, Inc.
Ron Newcomb has been named president and CEO of Resveratrol, Inc., a nutraceutical company. Newcomb plans to increase sales of Resveratrol’s three products, NutraGrape™, a dietary nutritional supplement made of Muscadine grape seeds; The Vine® facial cream and The Vine® body lotion. Muscadine grape seeds have very high levels of antioxidants, which help fight free radical damage to your body. - January 29, 2008 - NutraGrape
AnaSpec Introduces 9 New Antibody Products
Continuing to rapidly expand its antibody offerings, AnaSpec added nine (9) new antibody products to its growing collection. Anti-AKT pan (IN) - Cat# 54320, 50 µg Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; bovine; zebrafish; Applications: WB Anti-AKT pan (NT) - Cat#... - January 27, 2008 - AnaSpec, EGT Group
Bio-Synthesis Inc. Announces Exclusive Collaboration in the Area of Immune Agonists and Antagonists
Bio-Synthesis Inc., a closely held biotechnology company, is pleased to announce an exclusive scientific collaboration with Dr. Dante Marciani, a world renowned expert in immune agonists. Over the last 20 years, Dr. Marciani has pioneered work with proprietary immune stimulatory saponins and their... - January 25, 2008 - Bio-Synthesis Inc.
AnaSpec Announces a Broad Selection of T-Cell Epitopes
AnaSpec has announced the availability of a wide selection of T-Cell Epitopes, available both individually and pooled. - January 23, 2008 - AnaSpec, EGT Group
RNCOS Releases Report on Global Bioinformatics Market Outlook
“Global Bioinformatics Market Outlook” is the new addition in the report gallery of the leading market research firm RNCOS. The report provides detailed overview of the worldwide Bioinformatics industry. It examines the emerging trends of the market and provides exclusive forecasts,... - January 21, 2008 - RNCOS
RGBLase LLC Introduces Free Space Laser Module in Blue, Violet, Green and Red Wavelength
FreeBeam series temperature stabilized diode laser module features Violet 375 nm, Violet 405 nm, Blue 445 nm, Blue 473 nm, Green 532 nm, Red 639 nm and Raman 780 nm available now. - January 15, 2008 - RGBLase LLC
Monica Gavin MD, CEO Azani Medical Spa, is 1st Lehigh Valley PA Physician to Get Diplomate Certification from American Academy of Anti-Aging & Regenerative Medicine (A4M)
Azani Medical Spa, located in Bethlehem, PA, announced the Diplomate Certification status of Dr. Monica Carezani-Gavin through the American Academy of Anti-Aging and Regenerative Medicine (A4M). From its global membership of over 20,000 physicians and health practitioners from 90 countries, Dr. - January 09, 2008 - Azani Medical Spa
AnaSpec Introduces Ten New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid. MSL8; [Met256]-OVA (257-264)- Cat# 62573-5 Sequence: MSIINFEKL MSL8; [Met256]-OVA (257-264)- Cat# 62573-1 Sequence: MSIINFEKL OVA... - January 04, 2008 - AnaSpec, EGT Group
RNCOS Releases Report on Global Biometric Market
RNCOS released a report titled "Global Biometric Market - New Opportunities (2007-2010)" that provides extensive research and objective analysis of the global biometric technology. - January 02, 2008 - RNCOS
Avoiding Steroids and Their Side Effects Should be Component in New Year’s Resolution of Athletes, Law Enforcement and Paramilitary
Unparalleled drug-free gains in strength, stamina and mental performance attainable through natural energetic alternative to steroids and banned performance enhancing drugs providing powerful ergogenic effects rivaling steroids, blood doping and other dangerous performance enhancement techniques while enhancing deep delta sleep, cardiovascular efficiency, cellular repair and mental acuity. - January 01, 2008 - EarthPulse Tech, LLC
General Informatics Managing Partner Named Senior Editor of Technological Forecasting & Social Change
Dr. Fred Phillips has been named Senior Editor of Elsevier’s international journal Technological Forecasting & Social Change. Published continuously since 1967, TFSC publishes peer-reviewed advances in technology assessment, forecasting, and policy. - December 27, 2007 - General Informatics LLC